David Rescott
Stock Analyst at Baird
(3.58)
# 622
Out of 4,818 analysts
55
Total ratings
50%
Success rate
5.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Maintains: Outperform | $316 → $325 | $291.61 | +11.45% | 28 | Apr 24, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $72 → $75 | $75.48 | -0.64% | 4 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $115 → $120 | $100.59 | +19.30% | 5 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $505.00 | +13.86% | 3 | Apr 23, 2025 | |
| MDT Medtronic | Maintains: Neutral | $90 → $91 | $84.30 | +7.95% | 4 | Feb 19, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $107 → $109 | $94.60 | +15.22% | 2 | Oct 31, 2024 | |
| LIVN LivaNova | Maintains: Outperform | $66 → $72 | $36.95 | +94.86% | 3 | Oct 31, 2024 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $14.38 | +80.81% | 6 | Dec 22, 2023 |
Penumbra
Apr 24, 2025
Maintains: Outperform
Price Target: $316 → $325
Current: $291.61
Upside: +11.45%
Edwards Lifesciences
Apr 24, 2025
Maintains: Neutral
Price Target: $72 → $75
Current: $75.48
Upside: -0.64%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $115 → $120
Current: $100.59
Upside: +19.30%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $505.00
Upside: +13.86%
Medtronic
Feb 19, 2025
Maintains: Neutral
Price Target: $90 → $91
Current: $84.30
Upside: +7.95%
Merit Medical Systems
Oct 31, 2024
Maintains: Outperform
Price Target: $107 → $109
Current: $94.60
Upside: +15.22%
LivaNova
Oct 31, 2024
Maintains: Outperform
Price Target: $66 → $72
Current: $36.95
Upside: +94.86%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $14.38
Upside: +80.81%